Qube Research & Technologies LTD Anika Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $91.4 Billion
- Q3 2025
A detailed history of Qube Research & Technologies LTD transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 17,428 shares of ANIK stock, worth $173,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,428
Previous 21,658
19.53%
Holding current value
$173,234
Previous $229,000
28.82%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ANIK
# of Institutions
118Shares Held
10.7MCall Options Held
0Put Options Held
0-
Trigran Investments, Inc.1.62MShares$16.1 Million2.92% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA781KShares$7.76 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA633KShares$6.29 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX601KShares$5.98 Million0.0% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $145M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...